Legend Biotech Corp. (LEGN) PT Lowered to $58 at Raymond James
Despite a target cut, upside remains significant given current price.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Despite a target cut, upside remains significant given current price.
What happened, with direct paths to the underlying reporting
Raymond James lowers PT to $58; current price $18.87; still substantial upside potential remains.
Target: $58
Posted price: $18.87
Analyst firm: Raymond James
Analyst: Sean McCutcheon
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.